Xianglei Fu

493 total citations
18 papers, 343 citations indexed

About

Xianglei Fu is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Xianglei Fu has authored 18 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Biomedical Engineering and 4 papers in Biomaterials. Recurrent topics in Xianglei Fu's work include Nanoplatforms for cancer theranostics (5 papers), RNA Interference and Gene Delivery (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Xianglei Fu is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), RNA Interference and Gene Delivery (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Xianglei Fu collaborates with scholars based in China, United States and Netherlands. Xianglei Fu's co-authors include Guimei Lin, Yanbin Shi, Xiaogang Zhao, Yi Huang, Qifeng Sun, Shengnan Qiu, Guangxi Zhai, Yujia Zhai, Xiaoye Yang and Shan Gao and has published in prestigious journals such as Nature Communications, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Xianglei Fu

17 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianglei Fu China 9 140 121 77 62 46 18 343
Yanguo Su China 12 138 1.0× 84 0.7× 82 1.1× 48 0.8× 21 0.5× 18 363
Yifan Fang China 10 159 1.1× 121 1.0× 101 1.3× 39 0.6× 19 0.4× 27 390
Yuefei Fang China 8 140 1.0× 132 1.1× 73 0.9× 145 2.3× 33 0.7× 11 406
Kaipei Luo China 11 147 1.1× 103 0.9× 119 1.5× 55 0.9× 33 0.7× 15 354
Romain Brusini France 7 141 1.0× 94 0.8× 72 0.9× 52 0.8× 34 0.7× 8 415
Mengdi Jia China 8 172 1.2× 175 1.4× 144 1.9× 134 2.2× 36 0.8× 12 502
Tiep Tien Nguyen South Korea 13 159 1.1× 107 0.9× 75 1.0× 61 1.0× 25 0.5× 29 483
Po‐Han Chao Canada 9 149 1.1× 91 0.8× 103 1.3× 73 1.2× 30 0.7× 17 426
Sunil Kumar Surapaneni United States 15 281 2.0× 134 1.1× 96 1.2× 40 0.6× 29 0.6× 22 576
Hangsheng Zheng China 12 145 1.0× 149 1.2× 138 1.8× 40 0.6× 69 1.5× 24 388

Countries citing papers authored by Xianglei Fu

Since Specialization
Citations

This map shows the geographic impact of Xianglei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglei Fu more than expected).

Fields of papers citing papers by Xianglei Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianglei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglei Fu. The network helps show where Xianglei Fu may publish in the future.

Co-authorship network of co-authors of Xianglei Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Xianglei Fu. A scholar is included among the top collaborators of Xianglei Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglei Fu. Xianglei Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fu, Xianglei, Yanbin Shi, Yankun Zhang, et al.. (2025). Inhalable liposomal delivery of osimertinib and DNA for treating primary and metastasis lung cancer. Nature Communications. 16(1). 3336–3336. 7 indexed citations
2.
Fu, Xianglei, Shengnan Qiu, Yankun Zhang, et al.. (2025). ZIF-8-Modified Multifunctional Hydrogel Loading siRNA and DOX for Postoperative Therapy of Maxillofacial Osteosarcoma and Bone Repair. ACS Applied Materials & Interfaces. 17(12). 17990–18002. 3 indexed citations
3.
4.
Qiu, Shengnan, Yanbin Shi, Hengchang Zang, et al.. (2024). Multifunctional injectable microspheres for osteoarthritis therapy via spatiotemporally modulating macrophage polarization and inflammation. npj Regenerative Medicine. 9(1). 22–22. 5 indexed citations
5.
Qiu, Shengnan, Yanbin Shi, Hengchang Zang, et al.. (2024). Preparation and release pattern study of long-term controlled release Blonanserin microspheres. International Journal of Pharmaceutics. 666. 124756–124756. 1 indexed citations
6.
Chu, Shenghui, Xianglei Fu, Chao Jiang, et al.. (2024). Safflower polysaccharide ameliorates acute ulcerative colitis by regulating STAT3/NF-κB signaling pathways and repairing intestinal barrier function. Biomedicine & Pharmacotherapy. 174. 116553–116553. 22 indexed citations
7.
Liu, Yingying, Hengchang Zang, Yanbin Shi, et al.. (2024). A study on the treatment of rheumatoid arthritis with lipid nanoparticles containing mRNA encoding heat shock protein 10. Journal of Pharmaceutical Sciences. 114(2). 1455–1463. 1 indexed citations
8.
Fu, Xianglei, Yanbin Shi, Hengchang Zang, et al.. (2024). Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application. Asian Journal of Pharmaceutical Sciences. 19(3). 100925–100925. 8 indexed citations
9.
Wang, Wenxuan, Min Liu, Xianglei Fu, et al.. (2024). Hydroxysafflor yellow A ameliorates alcohol-induced liver injury through PI3K/Akt and STAT3/NF-κB signaling pathways. Phytomedicine. 132. 155814–155814. 16 indexed citations
10.
Liu, Na, Min Liu, Mengwei Jiang, et al.. (2023). Isoliquiritigenin alleviates the development of alcoholic liver fibrosis by inhibiting ANXA2. Biomedicine & Pharmacotherapy. 159. 114173–114173. 19 indexed citations
11.
Qiu, Shengnan, Xianglei Fu, Yanbin Shi, et al.. (2023). Relaxin-Loaded Inhaled Porous Microspheres Inhibit Idiopathic Pulmonary Fibrosis and Improve Pulmonary Function Post-Bleomycin Challenges. Molecular Pharmaceutics. 20(8). 3947–3959. 8 indexed citations
12.
Fu, Xianglei, Yanbin Shi, Hengchang Zang, et al.. (2022). Combination of oxaliplatin and POM-1 by nanoliposomes to reprogram the tumor immune microenvironment. Journal of Controlled Release. 347. 1–13. 23 indexed citations
13.
Qiu, Shengnan, Yanbin Shi, Hengchang Zang, et al.. (2022). Preparation of Injectable Double-Layer Microspheres for the Long-Term Treatment of Osteoarthritis. SSRN Electronic Journal. 1 indexed citations
14.
Wu, Hang, Xianglei Fu, Yujia Zhai, et al.. (2021). Development of Effective Tumor Vaccine Strategies Based on Immune Response Cascade Reactions. Advanced Healthcare Materials. 10(13). e2100299–e2100299. 40 indexed citations
15.
Fu, Xianglei, Yanbin Shi, Shengnan Qiu, et al.. (2020). Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting. Signal Transduction and Targeted Therapy. 5(1). 262–262. 103 indexed citations
16.
Shi, Yanbin, Yi Huang, Xianglei Fu, et al.. (2020). The role of antibody delivery formation in cancer therapy. Journal of drug targeting. 28(6). 574–584. 5 indexed citations
17.
Huang, Yi, Yanbin Shi, Qingjie Wang, et al.. (2019). Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma. Journal of Controlled Release. 316. 208–222. 33 indexed citations
18.
Fu, Xianglei, Yanbin Shi, Hui Wang, et al.. (2019). <p>Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4</p>. International Journal of Nanomedicine. Volume 14. 9275–9284. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanguo Su Breakdown of academic impact, for papers by Yifan Fang Breakdown of academic impact, for papers by Yuefei Fang Breakdown of academic impact, for papers by Kaipei Luo Breakdown of academic impact, for papers by Romain Brusini Breakdown of academic impact, for papers by Mengdi Jia Breakdown of academic impact, for papers by Tiep Tien Nguyen Breakdown of academic impact, for papers by Po‐Han Chao Breakdown of academic impact, for papers by Sunil Kumar Surapaneni Breakdown of academic impact, for papers by Hangsheng Zheng
Rankless by CCL
2026